16 August 2013 - Deborah Wilkes
Archived
South Africa's Adcock Ingram is still in exclusive talks with CFR Pharmaceuticals about the Chilean firm's US$1.3 billion takeover offer, but it has received further proposals.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.